A novel benzamine lead compound of histone deacetylase inhibitor ZINC24469384 can suppresses HepG2 cells proliferation by upregulating NR1H4

Scientific Reports
Qiuhang SongYuxin Li

Abstract

Histone deacetylases (HDACs) can enzymatically transferred acetyl functional group from protein or lysine residues of histone, so they can regulate the expression of lots of genes. Now HDACs are used as drug targets and many HDAC inhibitors (HDACis) were approved for cancer therapy or in clinical trials. However, the physiological mechanisms and regulatory processes of HDACi anti-cancer effects are largely unexplored and uncompleted. Here we use the virtual screening workflow obtained 25 hit compounds and ZINC24469384 can significantly inhibit HDAC activity while arrest cell cycle at G1/S phase and significantly induced HepG2 cell apoptosis, time-course RNA-seq demonstrate that HepG2 cells transcriptionally respond to ZINC24469384. Pathway analysis of DEGs and DASGs reveal that NR1H4 may play an important role in ZINC24469384-induced anti-proliferation effect and is dramatically alleviated by down-regulating the SOCS2 expression and promoting STAT3 phosphorylation in knockdown NR1H4 HepG2 cells. Analysis based on TCGA database indicated that NR1H4 and SOCS2 were downregulated in liver cancer, this suggest NR1H4 and SOCS2 may play an important role in tumorigenesis. These results indicated that ZINC24469384 is a novel benzamine ...Continue Reading

References

Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Nov 30, 2002·Expert Opinion on Investigational Drugs·William K KellyPaul A Marks
Sep 28, 2005·The Journal of Cell Biology·Teresa P BarrosJordan W Raff
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Oct 28, 2006·Cell Death and Differentiation·L M Rozan, W S El-Deiry
Mar 6, 2008·Neoplasia : an International Journal for Oncology Research·Hua XiongJing-Yuan Fang
Jun 11, 2008·BMC Bioinformatics·Xiong LiuJiang Qian
Jun 21, 2008·Molecular Cancer Therapeutics·Lulzim ShkretaBenoit Chabot
Jul 12, 2008·Journal of Hepatology·Graham P HayhurstMary C Weiss
Oct 1, 2008·Cancer Letters·Olaf WittIna Oehme
Dec 3, 2008·Cancer Research·Salvatore ModicaAntonio Moschetta
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew A Lane, Bruce A Chabner
Jul 10, 2010·Molecular and Cellular Endocrinology·Matthew D KrasowskiSean Ekins
Aug 7, 2010·Expert Opinion on Investigational Drugs·Paul A Marks
Oct 26, 2010·Nature Structural & Molecular Biology·Martin DutertreDidier Auboeuf
Nov 30, 2010·Recent Patents on Anti-cancer Drug Discovery·Vincenzo CarafaLucia Altucci
Mar 30, 2012·Omics : a Journal of Integrative Biology·Guangchuang YuQing-Yu He
Apr 28, 2012·Gene·Marta MontesCarlos Suñé
May 9, 2012·Cellular Signalling·Zhizhen XuFengtian He
Aug 4, 2012·Future Medicinal Chemistry·Giuseppe GianniniManuela Rodriquez
Nov 13, 2012·Molecular Oncology·Maria NewNicholas B La Thangue
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yanjun JiangNikolai A Timchenko
Mar 2, 2013·Cell Death & Disease·J E BoldenR W Johnstone
Nov 2, 2013·American Journal of Physiology. Gastrointestinal and Liver Physiology·Ann M BaileyGrace L Guo
Dec 18, 2013·Bioinformatics·Andreas KrämerStuart Tugendreich
Aug 21, 2014·Biochimica Et Biophysica Acta·Raffaella Maria GadaletaAntonio Moschetta
Feb 17, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Chun-Ju LiuFu-Sheng Wan
Apr 2, 2015·Nature Reviews. Drug Discovery·Malini Guha
Aug 11, 2015·Oncotarget·Li HeXing-Xing He
Sep 30, 2015·Oncotarget·Fei GuoFengtian He
Jul 26, 2016·BMC Pharmacology & Toxicology·Yan-Xin HuangYu-Xin Li
Oct 11, 2017·Nature Reviews. Clinical Oncology·Sumera RizviGregory J Gores

❮ Previous
Next ❯

Citations

Apr 15, 2019·Cellular and Molecular Life Sciences : CMLS·Srimanta PatraSujit K Bhutia
Jun 12, 2021·Bioorganic & Medicinal Chemistry·Raafat El-AwadyTaleb H Al-Tel

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
acetylation
flow cytometry
PCR
Xenograft
immunosorbent
electrophoresis

Software Mentioned

Modfit
EdgeR
SYBYL
R ClusterProfiler
ClusterProfiler
R studio

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.